Davita Inc vs Logitech International SA — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while Logitech International SA trades at $101.34 (market cap $14.63B). The key difference: Logitech International SA is the larger of the two by market cap, and Logitech International SA pays a 1.62% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Logitech International SA for 92 Days on average.
| DVA | LOGI | |
|---|---|---|
Market Cap | $11.28B | $14.63B |
Volume | 650,294 | 440,764 |
Sector | Health | Technology |
52-Week High | $240.96 | $126.69 |
52-Week Low | $103.87 | $85.84 |
Typical Hold Time | 113 Days | 92 Days |
Enterprise Value | $24.00B | $12.96B |
Dividend Yield | — | 1.62% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
Logitech (LOGI) trades at $101.50, down 0.89% today, with a bullish technical signal and strong fundamental performance. Recent earnings beats, including Q2 2026 EPS of $1.85 versus $1.26 expected, highlight operational strength. The company maintains robust profitability with a net margin of 16.28% and ROE of 35.29%, supported by new product launches like the Zone Vibe Pro headset and gaming partnerships.
Outlook remains positive with analyst consensus target of $107, offering ~5% upside, though risks include chip shortages and competitive pressures. Revenue growth is projected to reach $4.9B in 2026, but investor sentiment is mixed amid macroeconomic headwinds. The stock's valuation at P/E 18.75 appears reasonable given earnings trajectory.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →